Dusseldorf - Delayed Quote EUR

Arbutus Biopharma Corp (I9DN.DU)

Compare
3.1680
-0.0240
(-0.75%)
At close: January 10 at 7:32:07 PM GMT+1
Loading Chart for I9DN.DU
DELL
  • Previous Close 3.1920
  • Open 3.1920
  • Bid --
  • Ask --
  • Day's Range 3.1480 - 3.1920
  • 52 Week Range 2.0300 - 4.1760
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: I9DN.DU

View More

Performance Overview: I9DN.DU

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

I9DN.DU
6.74%
S&P 500
1.35%

1-Year Return

I9DN.DU
45.32%
S&P 500
22.51%

3-Year Return

I9DN.DU
3.12%
S&P 500
24.59%

5-Year Return

I9DN.DU
2.59%
S&P 500
77.94%

Compare To: I9DN.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: I9DN.DU

View More

Valuation Measures

Annual
As of 1/10/2025
  • Market Cap

    605.45M

  • Enterprise Value

    482.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    87.25

  • Price/Book (mrq)

    5.78

  • Enterprise Value/Revenue

    73.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: I9DN.DU

View More

Company Insights: I9DN.DU

Research Reports: I9DN.DU

View More